학술논문

Generation of a humanized Aβ expressing mouse demonstrating aspects of Alzheimer's disease-like pathology.
Document Type
article
Source
Nature communications. 12(1)
Subject
Brain
Animals
Mice
Inbred C57BL
Mice
Transgenic
Humans
Alzheimer Disease
Disease Models
Animal
Amyloid beta-Protein Precursor
Gene Expression Profiling
Neuronal Plasticity
Mutation
Female
Male
Gene Regulatory Networks
Amyloid beta-Peptides
Gene Ontology
Neurodegenerative
Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD)
Aging
Dementia
Acquired Cognitive Impairment
Neurosciences
Genetics
Alzheimer's Disease
Brain Disorders
2.1 Biological and endogenous factors
Neurological
Language
Abstract
The majority of Alzheimer's disease (AD) cases are late-onset and occur sporadically, however most mouse models of the disease harbor pathogenic mutations, rendering them better representations of familial autosomal-dominant forms of the disease. Here, we generated knock-in mice that express wildtype human Aβ under control of the mouse App locus. Remarkably, changing 3 amino acids in the mouse Aβ sequence to its wild-type human counterpart leads to age-dependent impairments in cognition and synaptic plasticity, brain volumetric changes, inflammatory alterations, the appearance of Periodic Acid-Schiff (PAS) granules and changes in gene expression. In addition, when exon 14 encoding the Aβ sequence was flanked by loxP sites we show that Cre-mediated excision of exon 14 ablates hAβ expression, rescues cognition and reduces the formation of PAS granules.